-
公开(公告)号:US20250066420A1
公开(公告)日:2025-02-27
申请号:US18696155
申请日:2022-09-27
Applicant: Kansas State University Research Foundation
Abstract: An immune checkpoint (PD-L1) inhibitor oligopeptide comprising the sequence GTRLKPLIICVQWPGL (SEQ ID NO:1), nucleic acids encoding the oligopeptide, and vectors and cells for delivery nucleic acids encoding the oligopeptide are disclosed. Methods of treating cancer and enhancing anti-tumor immunity are also disclosed.